[Chat messenger use in the care of patients with Parkinson's disease].

IF 0.9 4区医学 Q4 CLINICAL NEUROLOGY

Nervenarzt Pub Date : 2024-08-01 Epub Date: 2024-07-22 DOI:10.1007/s00115-024-01686-6

A Naegele, I Schwaninger, L Toenges, C Eggers, T Warnecke, C Weigand, J Klucken

{"title":"[Chat messenger use in the care of patients with Parkinson's disease].","authors":"A Naegele, I Schwaninger, L Toenges, C Eggers, T Warnecke, C Weigand, J Klucken","doi":"10.1007/s00115-024-01686-6","DOIUrl":null,"url":null,"abstract":"Background: The demand for chat messaging apps for communication between physicians, therapists and patients is increasing. The expectations for this form of communication and uncertainties regarding introduction and use are heterogeneous.Objective: The implementation of chat messengers in the care of patients with Parkinson's disease should be facilitated by recommendations regarding introduction and usage.Methods: Semi-structured interviews with neurologists and physiotherapists were conducted to capture the expectations and needs regarding the use of chat messengers. From the data analysis, recommendations were derived.Results: The expectations for technical functionality exceeded the chat messenger functions. This concerns, e.g., the connection of the chat messenger to the electronic patient file. There is a great deal of uncertainty, particularly when it comes to the applicable General Data Protection Regulations (GDPR). The recommendations relating to the use of chat messengers, data protection aspects, the design of such tools and methodological considerations can help to implement the tool as an additional communication channel.Conclusion: Practical recommendations regarding functionality, the use of chat messengers in everyday life and in relation to data protection are derived from the results. By improving knowledge, physicians and therapists can contribute to the successful establishment of chat messengers as an additional communication tool.","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":"714-720"},"PeriodicalIF":0.9000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11297055/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nervenarzt","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00115-024-01686-6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/22 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The demand for chat messaging apps for communication between physicians, therapists and patients is increasing. The expectations for this form of communication and uncertainties regarding introduction and use are heterogeneous.

Objective: The implementation of chat messengers in the care of patients with Parkinson's disease should be facilitated by recommendations regarding introduction and usage.

Methods: Semi-structured interviews with neurologists and physiotherapists were conducted to capture the expectations and needs regarding the use of chat messengers. From the data analysis, recommendations were derived.

Results: The expectations for technical functionality exceeded the chat messenger functions. This concerns, e.g., the connection of the chat messenger to the electronic patient file. There is a great deal of uncertainty, particularly when it comes to the applicable General Data Protection Regulations (GDPR). The recommendations relating to the use of chat messengers, data protection aspects, the design of such tools and methodological considerations can help to implement the tool as an additional communication channel.

Conclusion: Practical recommendations regarding functionality, the use of chat messengers in everyday life and in relation to data protection are derived from the results. By improving knowledge, physicians and therapists can contribute to the successful establishment of chat messengers as an additional communication tool.

查看原文本刊更多论文

[帕金森病患者护理中聊天信使的使用]。

背景：医生、治疗师和患者对聊天信息应用程序的需求日益增加。人们对这种交流形式的期望以及在引入和使用方面的不确定性各不相同：方法：对帕金森病患者进行护理时，应通过有关引入和使用的建议来促进聊天信息应用的实施：方法：对神经科医生和物理治疗师进行了半结构化访谈，以了解他们对使用聊天信使的期望和需求。方法：对神经科医生和物理治疗师进行了半结构式访谈，以了解他们对使用聊天信使的期望和需求，并通过数据分析提出建议：结果：对技术功能的期望超过了聊天信使的功能。这涉及聊天信使与电子病历的连接等问题。还有很多不确定因素，尤其是在适用的《通用数据保护条例》（GDPR）方面。与聊天信使的使用、数据保护方面、此类工具的设计和方法考虑有关的建议有助于将该工具作为额外的交流渠道加以实施：结论：从研究结果中得出了关于聊天工具的功能、在日常生活中的使用以及数据保护方面的实用建议。通过增进知识，医生和治疗师可以为成功建立聊天信使这一额外的交流工具做出贡献。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nervenarzt 医学-精神病学

CiteScore

2.50

自引率

18.20%

发文量

169

审稿时长

4-8 weeks

期刊介绍： Der Nervenarzt is an internationally recognized journal addressing neurologists and psychiatrists working in clinical or practical environments. Essential findings and current information from neurology, psychiatry as well as neuropathology, neurosurgery up to psychotherapy are presented. Review articles provide an overview on selected topics and offer the reader a summary of current findings from all fields of neurology and psychiatry. Freely submitted original papers allow the presentation of important clinical studies and serve the scientific exchange. Review articles under the rubric ''Continuing Medical Education'' present verified results of scientific research and their integration into daily practice.